The ideological inspirer of Eternity Life Clinics and the main engine of progress on the way to immortal life is Denys Chernyshov. Lawyer, cryptocurrency business consultant, invited expert on TV programs and digital media.
In addition, Denys is a specialist in the field of taxation, licensing, legal services for banking and investment, as well as protecting the interests of individuals and legal entities in international courts.
Founder and CEO of Eternity Companies, who inspires problem solving globally by bringing together the best specialists.
Marios Kyriazis qualified as a medical doctor (MD) from the University of Rome, Italy, and after preclinical work in the USA he worked as a clinician in acute medicine in Cyprus, and the UK.He subsequently qualified as a Gerontologist with interest in the biology of aging and became a Chartered Member of the academic organisation ‘Royal Society of Biology’ in the UK. He also has a post-graduate qualification in Geriatric Medicine from the Royal College of Physicians of London.
Other appointments include Member of the Board of Trustees at the Mediterranean Graduate School of Applied Social Cognition, affiliate researcher at the Evolution, Complexity and Cognition Group, University of Brussels, Expert assessor, (European Commission), Member Biological Complex Systems Alliance, and a Ronin Research Scholar.
Founder of “Just DNA Project” which is working on development of opensource bioinformatic pipelines and gene annotation modules.Bioinformatician at Systems Biology of Aging Group, senior scientist at CellFabrik.Anton is a bioinformatician working on life-extension and investigating aging.
Since 2015 he has dedicated his efforts to multi-omics analysis, and has accumulated extensive experience in bioinformatics. In particular, Anton has specialized in building next-generation sequencing pipelines, analyzing large datasets and applying machine learning to gene expression patterns.
He is an active open source developer, contributing to multiple bioinformatics projects. Additionally, he successfully designed genetic constructs in several mammalian synthetic biology projects.
Outside of academia, Anton is a co-founder of the International Longevity Alliance, a non-profit organization that is a platform for interaction between regional organizations that support anti-aging technologies.
Olga is a co-founder and scientific director of the MitoSpace mitochondrial therapy development platform. Olga is a speaker at numerous longevity congresses and schools.
For ten years, Olga worked in the scientific sector of the Center for Preventive Medicine “Saint Paulus German Diagnostic Center.
“She is a consultant of the association “Council for Nutritional and Environmental Medicine.” Member of the association COST
Doctor of Medical Sciences, Executive Director of the Global Longevity Institute, Associate Professor of the Department of Propaedeutics of Internal Medicine No. 2 of A. A. Bogomolets National Medical University, President of the Ukrainian Liver Foundation, Head of the Hepatological Center, gastroenterologist of the highest category, expert in functional medicine.
Siim Land is a biohacker, self-published bestselling author and an online entrepreneur.The topics cover range from health and fitness to productivity and mindset.
His ideas involve human life enhancement through body mind empowerment.
In academics, Siim has a Bachelor’s degree in Cultural and Social Anthropology, which gives me the skill of doing independent research and professional writing in any format or tone of voice.
Hugo Alexandre Ferreira is a medical doctor and physics engineer, holding a PhD in Physics on the topics of nanotechnologies applied to biomedicine.
He was founder and CEO of a biosensor nanotechnology company for in vitro diagnostics, and then worked for a multinational medical device company as an in vivo imaging expert prior to returning to academia.
Presently, he is a senior scientist at the Institute of Biophysics and Biomedical Engineering of the Faculty of Sciences of the University of Lisbon (FCUL).
He researches in neurosciences and oncology, with applications in longevity, using medical imaging, brain-computer interfaces and physiological computing. He is also an associate professor and coordinator of the BSc degree in Biomedical Engineering and Biophysics at FCUL
Ilia Stambler, PhD, is the Chief Science Officer and Chairman of “Vetek” (Seniority) Association – the Movement for Longevity and Quality of Life.
He is a fellow at the Department of Science, Technology and Society, Bar Ilan University, Israel, where he has received his PhD. His research has focused on the historical and social implications of aging and longevity research.
He has also been involved in mathematical modeling of aging and aging-related diseases.
Accomplished innovator with multiple patent filings and publications, he has been a pioneer in inclusive technologies having developed Hindawi Programming System for systems programming in Hindi and other Indian languages.
He is multidisciplinary trained in Pre-clinical Medicine, Neural Engineering, Medical Devices Technology, Telemedicine, Remote Diagnostics, Augmented Reality, Robotics & AI (Natural Language Processing, Machine Learning, Deep Learning, Analytics and Data Sciences).Qualifications also include MBA, Law, Clinical Psychology, Linguistics, Philosophy and Genetic Anthropology.
He started as a freelancer in 1996 working on embedded systems and has been an Entrepreneur between 2000 – 2006 building medical devices and autonomous robots.
His research areas are Brain Computer Interface and Brain Implants (electro-chemical implants for Parkinson’s disease, Alzheimer’s disease and developmental cognitive disorders), Technological Singularity and Transhumanism.
Dr. Bryan has been involved in nitric oxide research for the past 20 years and has made many seminal discoveries in the field. His many discoveries have resulted in dozens of issued US and International patents and the product technology resulting from his discoveries and inventions has improved patient care worldwide.
Dr. Bryan is an international leader in molecular medicine and nitric oxide biochemistry. He is a successful entrepreneur and has founded multiple companies. His technology is responsible for hundreds of millions of product sales worldwide.
Most recently, Dr. Bryan serves as Founder and CEO of Nitric Oxide Innovations, LLC, a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of nitric oxide-based therapies.
Dr. Joseph Purita obtained his B.S. and M.D. degrees from Georgetown University located in Washington, D.C. He is board certified in Orthopedic Surgery, Pain Management, and Stem Cell Therapy.
He has been actively involved in Regenerative Medicine for approximately the last twenty years. He is past president of the American Academy and Board of Regenerative Medicine.
He has lectured extensively throughout the world on stem cells, PRP and other topics in Regenerative Medicine such as aging pathways. He has published over twenty articles. He is currently the medical director of the Institute of Regenerative Medicine.
Psychologist, neuropsychologist, EFT therapist, certified specialist in the field of emotional intelligence and conflict resolution, member of the Ukrainian Association of Neuropsychology (UANP), member of the Ukrainian Union of Psychotherapists (USP), Ukrainian Association of Emotionally Focused Therapy (UAEFT), National Psychological Association of Ukraine (NPAU ), a participant in the psychotherapeutic training program on logotherapy and existential analysis by A. Lengle (GLE-International, Austria).
Pavel Borsky, M.D. is a scientist and entrepreneur dealing with different aspects of health and health care. Pavel works at the institute of Preventive Medicine at Charles University (CZE), he focuses mainly on aging research, trying to find out how to slow down the process of aging and how to successfully measure the rate of aging.
At the same time, he is a co-founder of a company engaged in the modernization of primary health care (Váš praktik), a project helping people understand their biological age (Vysetri.me) and a co-founder of a startup called Minus Age, which aims to provide easy access to the newest rejuvenation technologies.
Dr. Fossel has an MD and a PhD in neurobiology from Stanford University where he taught neurobiology and research methods. A clinical professor of medicine, he is considered to be the world foremost expert on telomeres, aging, and age-related disease.
He gave the first talk at the NIH on reversal of human aging, published the first medical articles (in JAMA) on the potential of telomeres as a clinical intervention, and authored the only medical textbook in this field, Cells, Aging, and Human Disease, by Oxford University Press. He served as editor-in-chief of Rejuvenation Research and OBM Geriatrics, as well as director of the American Aging Association.
Ksenia Tugay holds PhD in Life Sciences from the University of Lausanne. The subject of her PhD was dedicated to non-coding RNAs, type 2 diabetes and longevity. She has 6 years of experience in management of Innovation Programs across different industries and solid business background. Ksenia is an advisor to a Swiss FemTech startup PhenomX Health and she is also working as an innovation expert for a leading health Swiss Insurance.
Ksenia’s field of expertise is Digital Health and Wellness solutions in healthcare prevention and treatment. Ksenia is a strong advocate of Future’s Thinking and believes that disruptive technologies combined with shared economy, empathy and collaboration are the key to ending existing inequalities in healthcare.
Andrii’s background is in Molecular Biology, with a focus on early stage diagnostics of age-related disorders. During his studies and early practical research endeavours, he concentrated on the identification of epigenetic biomarkers.
His professional development has been concentrated on the improvement and popularization of the idea of biomarkers and the various tools available for their analysis. Andrii is now managing worldwide market analytics for biomarkers of Longevity and Aging in many practical facets of that sector.
Salome Mgaloblishvili qualified as a medical doctor (MD) from the Tbilisi State Medical University. Postgraduate Specialist Training in Clinical Hematology – P. L. Shupyk National Medical Academy of Postgraduate Education.
MD-Specialist in Clinical Hematology
Hematology Department of the Municipal Institution of Kyiv Regional Council “Kyiv Regional Oncology Dispensary”.
Head of Finance & IT department in Eternity Law International.
Chief Legal Officer in Steepay.
Graduated with Master of Laws degree from National Academy of Internal Affairs.
Michael Rose is a Distinguished Professor of Biology at the University of California, Irvine. He has been studying the biology of aging since 1976. He has received several scientific prizes, including the inaugural Bacon Prize in 2019.
After more than three hundred academic articles and ten academic books, his next book is “Conceptual Breakthroughs in the Evolutionary Biology of Aging.” Co-authored with Kenneth Arnold, it will be published later this year.
Dr Pellay is a passionate researcher and entrepreneur with interdisciplinary background focused on aging and rejuvenation research.For the past 13 years, he has been working for both academic and industrial research, looking at different aspects and possible therapeutic molecules to slow, arrest or even reverse the aging process.
Since 2015, he was leading a team dedicated to this goal within the Mediteranean Institute for Life Science (MedILS) in Split, Croatia. In 2020, he has set up biotech companies oriented towards rejuvenation medecine in partnership with experienced businessmen.
Dr. Maryna Polyakova studied medicine and specialized in psychiatry. After her clinical work with depression and dementia patients, she moved to research and worked in drug discovery for Alzheimer’s disease at the University of Vienna. Afterwards, she completed her PhD in cognitive neuroscience investigating biomarkers of late-life depression and mild cognitive impairment in the Max Planck Institute for human cognitive and brain sciences.
Currently, she runs research in the field of early diagnostics of dementia subtypes. Along with this Maryna is leading the project on Neurotech tree for the Foresight Institute, building a roadmap from existing technologies to the near and the most distant future of the brain.
José Pedro Castro concluded his PhD in Biomedicine, University of Porto. He then joined Prof. Tilman Grune’s lab in the German Institute of Human Nutrition (Potsdam, Germany) to study how aging contributes to proteostasis loss and cellular dysfunction in cells and animal models. Then, José joined Prof. Vadim Gladyshev’s lab at Harvard Medical School (Boston, USA) after being awarded with the highly competitive DFG Max-Kade Foundation fellowship to study the biology of aging using systemic approaches.
There, he has been involved in several projects, such as fast muscle fibers aging, validating in mice drug candidates predicted by transcriptomic signatures for lifespan extension and aging and testing early life effects of Rapamycin on mouse healthspan and lifespan, distinct longevity mechanisms across and within species and their association with aging, and the role of aging in the formation of B cell lymphoma.